Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Kussmaul, Meier & Polyarteritis Nodosa

Ruth Jessen Hickman, MD  |  Issue: April 2018  |  April 26, 2018

nukeaf / shutterstock.com

nukeaf / shutterstock.com

In 1866, Adolf Kussmaul, an internist, and Rudolf Maier, a pathologist, published the classic characterization of what eventually became known as polyarteritis nodosa.1 It was the first scientific clinical characterization of a noninfectious vasculitis. As such, it became a paradigmatic point of contrast to other types of vasculitides that were later described. Their description also provided key information about vasculitides that are still used to evaluate patients. Incorporating both precise clinical acumen and the latest in scientific technologies, the case continues to be a source of inspiration and guidance to today’s rheumatologists.

The New Scientific Era of Medicine

To understand the importance of the Kussmaul and Meier case, it is important to place it in the scientific context of the era. Eric Matteson, MD, MPH, is a professor of medicine in the divisions of rheumatology and epidemiology at the Mayo Clinic, in Rochester, Minn. One of Dr. Matteson’s interests is the history of medicine, particularly as it relates to rheumatology. “I think this medical history teaches us how we came to know what we know, and I think that’s important,” he explains. “It also shows us how difficult it is. That helps us know how medicine has advanced and was made more scientific and, ultimately, led to better understanding of the disease and its treatment.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This was an era in which scientific medicine was first being developed. Various procedures had been performed for hundreds of years, such as removing cataracts, setting wounds, performing amputations and lancing boils. But various superstitions, dubious potions and erroneous metaphysics existed alongside these practices. The scientific basis of disease did not start to become systematically explored until the 1800s or late 1700s.

“Our understanding began to improve with systematic teaching of anatomy initially, and then systematic teaching of pharmacology,” recounts Dr. Matteson. “Then came the advent of technologies like the microscope, the stethoscope and also some chemical analyses of different substrates, like urine.” Clinicians began bringing these tools into their clinical practice.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Diseases of the blood vessels have been known since antiquity, but inflammatory arterial disease had not been characterized. At the end of the 18th century, John Hunter made some of the first observations about diseases of inflammation associated with blood vessels in his observations on phlebitis.

Karl Rokitansky likely provided a description of a case of polyarteritis nodosa in 1852. Although he provided a compelling pathological description of aneurysmal findings seen in autopsy, it was only years later that one of his students examined the specimens under the microscope and found the characteristic changes of inflammation. Rokitansky mistakenly thought the changes were degenerative or hereditary in nature.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Vasculitis Tagged with:HistoryLost & Foundpolyarteritis nodosascientific methodVasculitis

Related Articles

    Rheum After 5: Dr. Eric Matteson Writes Rheumatic Disease History

    August 12, 2020

    Over the past 20 years, Eric L. Matteson, MD, MPH, emeritus chair, Division of Rheumatology, and emeritus professor of medicine at the Mayo Clinic College of Medicine and Science, Rochester, Minn., as well as a past president of the Rheumatology Research Foundation, has authored or co-authored six books about the history of rheumatic disease and…

    Medium-sized blood vessels are seen in the dermis and at the dermal-subcutaneous junction. The black arrow identifies a venule, and the blue arrow points to a fibrin deposition in the vessel wall. Extravasated neutrophils and erythrocytes are seen in the interstitium.

    Case Report: A Polyarteritis Nodosa Conundrum

    March 14, 2022

    Polyarteritis nodosa (PAN) is a systemic necrotizing vasculitis that typically affects medium-sized muscular arteries. The clinical subsets of PAN are idiopathic, generalized, secondary hepatitis B virus (HBV) associated and cutaneous PAN. These clinical subsets are important because of their therapeutic implications. Virtually any organ system can be affected in generalized PAN, but this vasculitis tends…

    Clues to Diagnosing, Managing Vanishing Aneurysms

    December 16, 2015

    Case report: A 27-year-old male was referred to the rheumatology outpatient department in February 2015 from the urology department after complaining of recent-onset uncontrolled hypertension (220/160 mmHg), headache and vomiting. In 2010, he was admitted to the urologist for sudden-onset left lumbar region pain and recent-onset hypertension. Clinical examination and the blood tests were normal….

    Case Report: Diagnosing, Treating Hepatitis B-Linked Polyarteritis Nodosa

    September 17, 2019

    Hepatitis B virus (HBV) associated polyarteritis nodosa (PAN) is an increasingly rare vasculitis in developed countries due to advances in HBV vaccination and antiviral therapy. However, the condition does persist, and rheumatologists should consider it when evaluating vasculitis cases. Below, we discuss a case that illustrates the varied clinical presentations PAN can encompass. A high…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences